(Q28214164)

Dendritic cells and the control of immunity

21 April 2017

1 reference

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

21 April 2017

1 reference

Anti-mRNA: specific inhibition of translation of single mRNA molecules

21 April 2017

1 reference

Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA.

21 January 2018

1 reference

Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication

21 January 2018

1 reference

Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena

21 January 2018

1 reference

The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme

21 January 2018

1 reference

Simple RNA enzymes with new and highly specific endoribonuclease activities

21 January 2018

1 reference

Ribozymes and their medical implications

21 January 2018

1 reference

Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics

21 January 2018

1 reference

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

21 January 2018

1 reference

Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

21 January 2018

1 reference

mRNA localization signals can enhance the intracellular effectiveness of hammerhead ribozymes

21 January 2018

1 reference

Synthesis, deprotection, analysis and purification of RNA and ribozymes

21 January 2018

1 reference

Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes

21 January 2018

1 reference

U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

21 January 2018

1 reference

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

21 January 2018

1 reference

Effective expression of small interfering RNA in human cells

21 January 2018

1 reference

Group II introns designed to insert into therapeutically relevant DNA target sites in human cells

21 January 2018

1 reference

Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing

21 January 2018

1 reference

Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells

21 January 2018

1 reference

Ribozyme-mediated trans-splicing of a trinucleotide repeat.

21 January 2018

1 reference

Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts

21 January 2018

1 reference

Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors

21 January 2018

1 reference

Spliceosome-mediated RNA trans-splicing as a tool for gene therapy

21 January 2018

1 reference

Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing

21 January 2018

1 reference

Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy?

21 January 2018

1 reference

Design of highly specific cytotoxins by using trans-splicing ribozymes.

21 January 2018

1 reference

Optimizing the substrate specificity of a group I intron ribozyme

21 January 2018

1 reference

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

Developing aptamers into therapeutics

21 January 2018

1 reference

Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor

21 January 2018

1 reference

2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain

21 January 2018

1 reference

Escort aptamers: a delivery service for diagnosis and therapy

21 January 2018

1 reference

Selection of single-stranded DNA molecules that bind and inhibit human thrombin

21 January 2018

1 reference

Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass

21 January 2018

1 reference

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys

21 January 2018

1 reference

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

21 January 2018

1 reference

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

21 January 2018

1 reference

HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response.

21 January 2018

1 reference

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

21 January 2018

1 reference

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease

21 January 2018

1 reference

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

21 January 2018

1 reference

Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro

21 January 2018

1 reference

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

21 January 2018

1 reference

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

Do human cancers express shared protective antigens? or the necessity of remembrance of things past

21 January 2018

1 reference

The makings of a tumor rejection antigen

21 January 2018

1 reference

Trans -splicing ribozymes for targeted gene delivery 1 1Edited by J. Karn

21 January 2018

1 reference

A small catalytic oligoribonucleotide

21 January 2018

1 reference

The role of antisense RNA in gene regulation.

21 January 2018

1 reference

7 January 2021

The use of RNAs complementary to specific mRNAs to regulate the expression of individual bacterial genes

1 reference

7 January 2021

1 reference

7 January 2021

A phase I trial of autologous CD34 hematopoietic progenitor cells transduced with an anti-HIV ribozyme

1 reference

7 January 2021

Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance

1 reference

7 January 2021

Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing

1 reference

7 January 2021

Diversity of oligonucleotide functions

1 reference

7 January 2021

Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8 T cell responses to infectious agents, tumors, transplants, and vaccines

1 reference

7 January 2021

Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA

1 reference

7 January 2021

Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA

1 reference

7 January 2021

Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin

1 reference

7 January 2021

Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

1 reference

7 January 2021

mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)

1 reference

7 January 2021

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 reference

7 January 2021